Italia markets closed

TEVA Jul 2024 19.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,22000,0000 (0,00%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,2200
Aperto0,2200
Denaro0,0000
Domanda1,2700
Prezzo d'esercizio19,00
Scadenza2024-07-12
Min-Max giorno0,2200 - 0,2200
Contratto - Min-MaxN/D
Volume1
Open Interest3
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.